BIBLIOGRAFIA
1. Mokdad AH, Serdula MK, Dietz WH et al. The spread of the obesity epidemic in the United States, 1991-1998. JAMA 1999;282:1519-1522.
2. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heat CW. Body-mass index and mortality in a prospective cohort of U.S. adults. New Engl J Med 1999;341:1097-1105.
3. Aronne LJ 2001. Epidemiology, morbidity and treatment of overweight and obesity. J Clin Psychiatry 62 (suppl 23), 13-22.
4. Dixon L, Postrado L, Delahanty J, et al. The association of medical comorbidity in schizophrenia with poor physical and mental health. J Nerv Ment Dis 1999;187:496-502.
5. Remington G, Chong S, Conventional versus novel antipsychotics: changing concepts and clinical implications. J Psychiatry Neurosci 1999; 25: 431-441.
6. Planansky K, Heilizer F. Weight changes in relation to the characteristic of patients on chlorpromazine. J Clin Exp Psychopathol Q Rev Psychiatry Neurol 1959;20 :53-57.
7. Klett C, Caffey E. Weight changes during treatment with phenothiazine derivatives. J Neuropsychiatry 1960;2:102-108.
8. Doss FW. The effect of antipsychotic drugs on body weight: a retrospective review. J Clin Psychiatry 1979;40:528-530.
9. Allison DB, Mentore JL, Heo M, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999;156:1686-1696.
10. Kelly DL, Conley RR, Love RC et al. Weight gain in adolescents treated with risperidone and conventional antipsychotic over six months. J Child Adolesc Psychopharmacol 1998;8:151-159.
11. Hummer M, Kemmler G, Kurz M et al. Weight gain induced by clozapine. Eur Neuropharmacol 1995;5:437-440.
12. Conley RR, Meltzer HY. Adverse events related to olanzapine. J Clin Psychiatry 2000; 61 (suppl 8):26-29.
13. Vettor R, Fabris R, Pagano C, Federspil G. Neuroendocrine regulation of eating behavior. J. Endocrinol. Invest. 2002;25:836-854.
14. Stunkard A, Harris J, Pedersen N, McClearn G. The body mass index of twins who have been reared apart. New Engl J Med 1990; 322:1483-1487.
15. Lustig RH. The neuroendocrinology of obesity. Endocrinol Metab Clin North Am 2001;30:765-785.
16. McIntyre RS, Mancini DA, Basile VS. Mechanism of antipsychotic-induced weight gain. J Clin Psychiatry 2001; 62 (suppl 23):23-29.
17. McIntyre RS, McCann SM, Kennedy SH. Antipsychotic metabolic effects: weight gain, diabetes mellitus and lipid abnormalities. Can J Psychiatry 2001;46:273-281.
18. Hagg S, Soderberg S, Ahren B, Olsson T, Mjorndal T. Leptin concentrations are increased in subjects treated with clozapine or conventional antipsychotics. J Clin Psychiatry 2001;62: 843-848.
20. Basile VS, Masellis M, McIntyre RS, Meltzer HY, Lieberman JA, Kennedy JL. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle. J Clin Psychiatry 2001, 62 (suppl 23):45-66.
21. Floris M, Lejeune J, Deberdt W. Effect of amantidine on weight gain during olanzapine treatment. Eur Neuropsychopharmacol 2002;11:181-182.
22. Wirshing DA, Wirshing WC, Kysar L, et al. Novel antipsychotics: comparison on weight gain liabilities. J Clin Psychiatry 1999;60:358-363.
23. Nasrallah H. A review of the effect of atypical antipsychotics on weight. Psychoneuroendocrinology 2003; Suppl.1, 83-96.
24. Meguid MM, Fetissov FO, Varma M, et al. Hypothalamic dopamine and serotonin in the regulation of food intake. Nutrition 2000;16:843-857.
25. Tecott LH, Sun LM, Akana SF, et al. Eating disorder and epilepsy in mice 5-HT2c serotonin receptors. Nature 1995;374:542-546.
26. Halbreich U, Kinon BJ, Gilmore JA, Kahn LS. Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects. Psychoneuroendocrinology 2003; 28:53-67.
27 . C Das, G Mendez, S Jagasia, LA Labbate Second-generation antipsychotic use in schizophrenia and associated weight gain: a critical review and meta-analysis of behavioral and pharmacologic treatments. Annals of clinical psychiatry, 2012;24(3):225-239
28. Taylor VH, McIntyre RS, Remington G, Levitan RD, Stonehocker B, Sharma AM.Beyond pharmacotherapy: understanding the links between obesity and chronic mental illness.authors. Can J Psychiatry. 2012 Jan;57(1):5-12
29. T A P Lett, T J M Wallace, N I Chowdhury, A K Tiwari, J L Kennedy and D J Müller Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications Molecular Psychiatry (2012) 17, 242–266
30. Marc de Hert et al.Metabolic syndrome in people with schizophrenia: a review. World Psychiatry,Volume 8, Issue 1, pages 15–22, February 2009
